Four hundred and four patients who were admitted to the hospital with their first myocardial infarction within 24 hours of the onset of symptoms were studied. In 315 patients the ECG findings in 12 standards leads (I, II, aVF, aVR, aVL, V,-V6) showed the infarction to be in the anterior wall, the inferior wall, or in multiple areas. The patients in each of these three categories were further subdivided into two groups according to the magnitude of the ST-elevation; those witi major ST-elevation and those with minor ST-elevation. Occurrence of the risk factors of diabetes, hypertension, hyperlipidemias, age, and complicating chronic pulmonary and renal diseases were comparable, but since women predominated in one group (anterior wall infarction/ minor ST-elevation) the clinical course of the disease in men and women was studied separately. The patients with major ST-elevation had a more unfavorable course: cardiac arrest (P < 0.0005), congestive heart failure (P < 0.0005), death (P< 0.001), atrial fibrillation (P < 0.005), cardiogenic shock (P <0.005), atrioventricular (A-V) block 2°-3°(P <0.01), and ventricular extrasystoles and ventricular tachycardia (P <0.025) all occurred with significant frequency. 
PARAMETERS related to the size of infarction are often used when evaluating patients with acute myocardial infarction. A reasonably accurate clinical correlation between the maximum serum enzyme elevation and the extent of the infarction determined at post mortem has been established in earlier studies. ' The correlation between the mortality rate and the serum glutamic oxaloacetic transaminase (SGOT), and lactic dehydrogenase (LDH) is highly significant. 2 While serum enzyme values can be used as a rough guide to the extent of the infarction,3 4 animal experiments5 6 and exercise and arteriographic studies on patients7 have shown that deviation of the ST-segment reflects myocardial ischemia, and that ST-elevation indicates a more severe degree of ischemia than ST-depression.6 , '
Both the duration and magnitnde of the STelevation and the number of leads recording STelevation have been used for diagnostic and prognostic evaluation. An early reversal of the STelevation in standard leads has thus been read as an expression of effective treatment of patients with acute myocardial infarction (AMI').9 With surface mapping of the ST-segment deviations using multiple surface electrodes, it has been possible to demonstrate an abnormal pattern in patients with acute myocardial infarction whose standard leads are abnormal, and in some patients with myocardial infarction when the standard electrocardiogram is normal.10 11 Maroko et al. have shown that the sum of ST-segment elevation in multiple precordial leads (5. S-T) can be used as an index of tissue injury and the number of sites with ST-elevation (NS-T) as an expression of the extent of myocardial ischemic injury, and that both parameters can be changed by pharmacologic and hemodynamic intervention. 12' 13, 14 If the magnitude of ST-eleva- The ST-elevation was measured on the ECG using the T-P-segment as the isoelectric line. The deviation was measured in mm to the nearest 0.5 mm at 0.06 sec after the nadir of the S svave, when this was present. In most patients without an S wave, the deviation was measured 0.06 sec after the nadir of the QS-complex, or from the Q wave. In a very few patients without welldefined S, QS, or Q waves, the R wave was used as the starting point. Under this definition ST-elevation in patients with broad QRS complexes (0.12 sec or more) and bundle branch block (BBB) could not be measured. Patients fifteen patients out of 404 were included in these 3 groups. Of the remaining 89 patients, ten presumably had a strictly posterior infarction. In 79 patients the site of infarction was uncertain. All patients with broadened QRS and/or BBB were included in this group. No further analysis was made of these 89 patients.
In the group of patients with anterior wall infarction, 79 patients had major ST-elevation (> 5.0 mm) in one or more leads (I, aVL, V1 6), while the remaining 68 patients had minor STelevation. Fifty-four patients in the group with inferior wall infarction had major ST-elevation ('2.0 mm) in one or more leads (II, III, aVF); the remaining 49 had minor ST-elevation. In the group with multiple infarctions, 25 patients had ST-elevation > 3.0 mm in one or more leads (I, aVL, V1 6) and ST-elevation of .2.0 mm (major elevation) in leads II, III, and aVF. The remaining 40 had minor ST-elevation.
Thus in the total group, 158 patients had major ST-elevation and 157 patients, minor ST-elevation. Definitions for major and minor ST-elevation were selected which would result in groups of almost equal size.
Comparability
Risk factors (diabetes mellitus, hypertension, and hyperlipidemia), complicating diseases (chronic pulmonary and renal diseases) and patients 60 years and older had the same frequency when the patients were grouped according to the location of the infarct. The distribution of these factors remained unchanged when these groups were further subdivided into those with major and minor ST-elevations.
A significant predominance of women was demonstrated in the group with anterior wall infarction and minor ST-elevation (x2 = 5.268, P <0.025), which is also reflected in the composition of the total group with minor ST-elevation (X2 = 4.386, P < 0.05). As a result of this difference men and women were studied separately. Frequency of other complications was also studied. Supraventricular tachycardia (atrial tachycardia, paroxysmal atrial tachycardia [PAT] with block and nodal tachycardia) took place with the same frequency in patients with minor ST-elevation as in those with major elevation of this segment (6%). More patients with multiple infarctions (15% ) experienced supraventricular tachycardia, but those with inferior wall infarction had this complication only rarely (1%).
Congestive heart failure was demonstrated in 49% of all patients with minor ST-elevation but in 70% of the patients with major ST-elevation (x2 = 13.0107, P < 0.0005). The correlation between congestive heart failure and major ST-elevation is statistically significant in patients with anterior wall infarction (X2 11.8255, P < 0.001), and particularly in male patients (x2 = 14.8251, P < 0.0005).
Ten percent of all patients developed thromboembolic complications, with a comparable rate for those in minor and in major ST-elevation groups. The distribution did not follow the same pattern as congestive heart failure. Pneumonia was diagnosed in 24% of all patients, most frequently in the groups with a high incidence of congestive heart failure, a fact which would suggest that many of these cases were hypostatic pneumonia. Comparing the subgroups within the major breakdown according to ST-elevation, the study found that major STelevation was significantly related to a higher frequency of development of pneumonia only in the group of patients with anterior wall infarction (X2 = 5.1229, P < 0.025). Of the total, 165 patients had ST-elevation in "a few leads," and 24 died (14.5%). A total of 150 patients had ST-elevation in "many leads," and of these, 21 died (14.0%). As can be seen, the magnitude of the ST-elevation, and not the number of leads with ST-elevation, is a helpful predictive tool.
Discussion
Why ST-elevation occurs is uncertain. Some have suggested that the true shift in the ST-segment is a manifestation of both earlier repolarization of myocardial cells in the injured area and a current of injury which deviates the TQ-segment.5 11 Recordings in epicardial leads have been used to define the boundaries of experimentally-induced myocardial infarction in animals15' 16 and to study the alterations in the area of ischemic tissue.17 Electrograms recorded from the surface of the heart usually cannot be taken without considerable risk to the patient. However, Maroko et al.12 ' 13, 14 showed that a noninvasive technique with multiple surface electrodes provides the same information in animals as insertion of epicardial electrodes and that the sum of ST-elevation in precordial leads (E S-T) is an index of tissue injury and the number of leads in which ST-elevation exceeds 0.1 mV (NS-T) reflects the extent of myocardial ischemic injury.
The duration of the ST-elevation has not been the subject of further analysis here, although previous studies have suggested that this parameter is of clinical value.9 Maroko et al. have used precordial ST-segment elevation mapping with 35 surface electrodes in 19 patients with acute myocardial infarction. In three patients in whom ventricular fibrillation, arterial hypotension, and further ischemic pain occurred, X S-T, and NS-T increased, whereas in one patient propranolol decreased the same parameters. The study suggests that this atraumatic method enables evaluation to be made of acute changes of ischemic injury caused by the hemodynamics of pharmacological intervention, which alter myocardial oxygen consumption or coronary perfusion.14 The importance of the number of leads recording ST-elevation has not been discussed in detail here either. In a previous investigation the magnitude of ST-elevation and the number of leads in which STelevation was seen were significantly related. A pronounced ST-elevation usually meant that there was ST-elevation in many leads (unpublished data). The number of leads with ST-elevation is not NIELSEN helpful in determining the risk of death, as stated above.
There are some good reasons to ascribe little clinical prognostic value to the magnitude of the ST-elevation in 12 standard leads in daily recordings, and these factors should be discussed in the light of our findings of the value of this measure. The leads do not cover the posterior wall of the heart and some parts of the septum and lateral wall, and the number of leads is so small that it is possible that the area with the most intense ischemia is missed by this method. In addition, if continuous monitoring of the ECG had been followed, ST A number of patients included in the group with major ST-elevation could have been included on the basis of only brief periods of pronounced STelevation, even though for most of the time only a slight elevation was noted.22 Patients were included in the group, major ST-elevation, regardless of whether the episode of ischemia recorded was brief, caused by the natural course of the disease, or brought about by the treatment.
Drugs did not greatly affect division of patients into groups with minor and major ST-elevation. The study included only patients with their first myocardial infarction and the majority of these patients had not been under treatment prior to admission. The maximum ST-elevation in the majority of cases was registered on the first ECG, i.e., before treatment was commenced (unpublished data).
Even though the study demonstrates that many complications occur more frequently in patients with major ST-elevation than in patients with minor ST-elevation, many factors other than myocardial ischemia-for example, the site of the infarction and the treatment given-may have brought on the complication. These additional possible contributing factors are discussed here in relation to each complication.
Atrial Fibrillation and Paroxysmal

Supraventricular Tachycardia
The cause of atrial fibrillation in patients with acute myocardial infarction, often in paroxysms, is unknown, but it is generally considered that there are multiple etiological factors, partly primary (diseases of the sinus node or atrial muscle, distention of right atrium, metabolic disturbances), and partly precipitating (toxic, hypoxic, neurogenic, mechanical) .23 In addition, atrial fibrillation/flutter occurs most often in patients with occlusion of the right coronary artery, which in the majority of patients supplies both the sinus inode and A-V node. 24 This study confirms that atrial fibrillation/flutter occurs most frequently in patients with occlusion of the right coronary artery (patients with inferior wall infarction and multiple infarctions), but this type of arrhythmia is not uncommon in patients with anterior wall infarction. Irrespective of the site of the infarction atrial fibrillation is seen most frequently in patients with major ST-elevation, most significantly in patients with inferior wall infarction. A pronounced localized myocardial ischemia therefore appears to be among the factors that can give rise to atrial fibrillation.
James25 found in a series including 11 necropsied patients with myocardial infarction and atrial arrhythmias (including atrial tachycardia) that all had had a coronary occlusion proximal to the origin of the sinus node artery and there was infarction of the sinus node.
Our results, however, do not support the assumption that atrial fibrillation/flutter and paroxysmal supraventricular tachycardia (atrial tachycardia, atrial tachycardia with block, nodal tachycardia) have the same etiology. Supraventricular tachycardia is demonstrated significantly more rarely in patients with inferior wall infarction than in patients with anterior wall infarction (X2 = 4.186, P < 0.05) and those with multiple infaretions, and in all the groups studied it is clear that the magnitude of the ST-elevation has no influence on the incidence. The frequency of paroxysmal supraventricular tachycardia is greatest in patients with multiple infarctions.
Circulation, Volume XLVIII, August 1973 A-V Block A-V block, like atrial fibrillation, occurs most frequently in patients with involvement of the right coronary artery,24 and this is confirmed by our results.
It has been suggested that the cause of A-V block in patients with inferior wall infarction is reversible ischemia in the A-V node and bundle,24 while A-V block in patients with anterior wall infarction is caused by total or subtotal destruction of both bundle branches, with little or no involvement of the A-V node and the main bundle.24'26 From this one would expect that patients with inferior wall infarction would show A-V block most often combined with pronounced ST-elevation (caused by ischemia); that patients with multiple infarctions and presumed involvement of several coronary arteries would show both mechanisms (ischemia and destruction of both bundle branches); and that the patients with anterior wall infarction would not demonstrate any connection between the ST-elevation and the occurrence of A-V block.
This presumption is found to be correct. In patients with inferior wall infarction A-V block is demonstrated more than ten times as frequently in patients with pronounced ST-elevation as in patients with minor ST-elevation, and in patients with multiple infarctions A-V block is found to be nonsignificantly increased in patients with major STelevation over those with minor ST-elevation. In patients with anterior wall infarction A-V block occurs with no greater frequency in patients with major ST-elevation as in those with minor ST-elevation. In our own study the highest incidence of shock is seen in patients with multiple infarctions (19%), while 9% of the patients in the other groups developed shock. This supports to some degree the presumed correlation between shock and the amount of myocardial tissue affected by the infarction.
Shock is found significantly more frequently in patients with major ST-elevation than in those with minor ST-elevation, and in patients with anterior wall infarction even 15 times more frequently. A possible explanation may be that myocardial ischemia is aggravated by hypotension and the accompanying systemic hypoxia. In addition, these critically ill patients are often given a drug which must be presumed to increase the magnitude of the ST-elevation (digoxin, glucagon, isoproteronol ) 12 Care Units is generally 10-25%,28 depending upon the diagnostic criteria, the time of admission, distribution according to age and sex, and possibly on the various types of treatment. In this survey the mortality rate was 14%, but the figure is of no great interest as the survey does not include either patients with cardiac arrest on admission or patients admitted after the first 24 hours of the onset of symptoms.
In the groups studied the death rate is two to four times higher in patients with major ST- elevation than in patients with minor ST-elevation.
The difference is statistically significant in patients with anterior wall infarction, in men, and in the total group. This is not surprising as the study has also shown a significantly greater frequency of the complications which most often lead to death in patients with major ST-elevation (cardiac arrest, congestive heart failure, A-V block 2°-3°, cardiogenic shock).
While all the results, which have been obtained in this study by using maximum values of the ST- elevation in standard leads, are in agreement with conclusions obtained by Maroko et al. using X S-T,14 it does not appear that the number of standard leads with ST-elevation (NS-T) alone can be used to evaluate the risk of death. It is, however, possible that the ST-elevation and the number of leads with elevation together might result in a more reliable prognostic evaluation.
